EVE.H — Eve & Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Eve & Co, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2017 October 31st | 2018 October 31st | 2019 December 31st | 2020 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PRESS | PRESS | ARS | ARS |
Standards: | — | — | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | — | — | 3.71 | 3.82 |
Cost of Revenue | ||||
Gross Profit | — | — | 0.387 | -2.71 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 1.24 | 9.15 | 9.33 | 13.7 |
Operating Profit | -1.24 | -9.15 | -5.62 | -9.87 |
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -1.24 | -9.14 | -5.53 | -9.81 |
Provision for Income Taxes | ||||
Net Income After Taxes | -1.24 | -9.14 | -5.71 | -9.81 |
Net Income Before Extraordinary Items | ||||
Net Income | -1.24 | -9.14 | -5.71 | -9.81 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -1.24 | -9.14 | -5.71 | -9.81 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.088 | -0.566 | -0.21 | -0.339 |